Kimberly-Clark plans to acquire Kenvue Inc., a personal care product provider with brands like Tylenol, in a deal that values the target at about $48.7 billion. The cash and stock transaction is expected to close in the second half of 2026.
“We are excited to bring together two iconic companies to create a global health and wellness leader,” said Mike Hsu, Kimberly-Clark Chairman and Chief Executive Officer. “Kenvue is uniquely positioned at the intersection of CPG and healthcare, with exceptional talent and a differentiated brand offering serving attractive consumer health categories. With a shared commitment to developing science and technology to provide extraordinary care, we will serve billions of consumers across every stage of life.
For details, click here to read the press release.
